Cargando…
Anti-PD1 and Anti-PDL1-Induced Hypophysitis: A Cohort Study of 17 Patients with Longitudinal Follow-Up
Hypophysitis, secondary to programmed cell death 1 protein (PD1) and programmed cell death 1 ligand 1 (PDL1) inhibitors, were thought to be rare, with only a few studies describing more than one case with long-term follow-up. The aim of the present study was to describe the clinical, laboratory, and...
Autores principales: | Levy, Manon, Abeillon, Juliette, Dalle, Stéphane, Assaad, Souad, Borson-Chazot, Françoise, Disse, Emmanuel, Raverot, Gérald, Cugnet-Anceau, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601962/ https://www.ncbi.nlm.nih.gov/pubmed/33066179 http://dx.doi.org/10.3390/jcm9103280 |
Ejemplares similares
-
Graves’ Disease during Immune Checkpoint Inhibitor Therapy (A Case Series and Literature Review)
por: Peiffert, Mathilde, et al.
Publicado: (2021) -
Pheochromocytoma, paragangliomas, and pituitary adenoma: An unusual association in a patient with an SDHD mutation. Case report
por: Lemelin, Annie, et al.
Publicado: (2019) -
Age- and Sex-Specific TSH Upper-Limit Reference Intervals in the General French Population: There Is a Need to Adjust Our Actual Practices
por: Raverot, Véronique, et al.
Publicado: (2020) -
Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
por: Lei, Qingyang, et al.
Publicado: (2020) -
Immunotherapy for Soft Tissue Sarcomas: Anti-PD1/PDL1 and Beyond
por: Fazel, Mina, et al.
Publicado: (2023)